31.05.2020 Views

Vol. 13 Issue 2

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Washington University Review of Health Spring 2020

Rural Healthcare Disparity: A National Concern

Writer: Rachel Ulbrich | Editor: Daniel Berkovich | Illustrator: Jennifer Broza

References

Anderson, L.A. (Ed.). (2019). PCSK9 Inhibi

tors: A New Option in Cholesterol Treatment.

Drugs.Com. Retrieved April 22, 2020, from

https://www.drugs.com/slideshow/pcsk9-inhibitors-a-new-option-in-cholesterol-treatment-1166

Centers for Disease Control and Prevention, Division

of Population Health. BRFSS Prevalence

& Trends Data (2015). https://www.cdc.gov/

brfss/brfssprevalence/index.html

Chapman, M. J., Stock, J. K., & Ginsberg,

H. N. (2015). PCSK9 inhibitors and cardiovascular

disease: Heralding a new therapeutic

era. Current Opinion in Lipidology,

26(6), 511–520. https://doi.org/10.1097/

MOL.0000000000000239

Do, R. Q., Vogel, R. A., & Schwartz, G. G. (2013).

PCSK9 Inhibitors: Potential in Cardiovascular

Therapeutics. Current Cardiology Reports,

15(3), 345. https://doi.org/10.1007/s11886-

012-0345-z

Karalis, D. G., Victor, B., Ahedor, L., & Liu, L.

(2012). Use of Lipid-Lowering Medications

and the Likelihood of Achieving Optimal

LDL-Cholesterol Goals in Coronary Artery

Disease Patients. Cholesterol, 2012. https://

doi.org/10.1155/2012/861924

Munjal, R. (2019, May 27). Are PCSK9 inhibitors

about to take off? PharmaTimes. http://

www.pharmatimes.com/web_exclusives/are_

pcsk9_inhibitors_about_to_take_off_1289184

Ray, K. K., Wright, R. S., Kallend, D., Koenig, W.,

Leiter, L. A., Raal, F. J., Bisch, J. A., Richardson,

T., Jaros, M., Wijngaard, P. L. J., & Kastelein, J.

J. P. (2020). Two Phase 3 Trials of Inclisiran

in Patients with Elevated LDL Cholesterol.

New England Journal of Medicine, 382(16),

1507–1519. https://doi.org/10.1056/NEJ-

Moa1912387

Roth, E. M., Moriarty, P. M., Bergeron, J.,

Langslet, G., Manvelian, G., Zhao, J., Baccara-Dinet,

M. T., & Rader, D. J. (2016). A phase

III randomized trial evaluating alirocumab 300

mg every 4 weeks as monotherapy or add-on

to statin: ODYSSEY CHOICE I. Atherosclerosis,

254, 254–262. https://doi.org/10.1016/j.

atherosclerosis.2016.08.043

Sabatine, M. S., Giugliano, R. P., Keech, A. C.,

Honarpour, N., Wiviott, S. D., Murphy, S. A.,

Kuder, J. F., Wang, H., Liu, T., Wasserman, S. M.,

Sever, P. S., & Pedersen, T. R. (2017). Evolocumab

and Clinical Outcomes in Patients with

Cardiovascular Disease. New England Journal

of Medicine, 376(18), 1713–1722. https://doi.

org/10.1056/NEJMoa1615664

W

e don’t have time to

wait for the ambulance

to get here.

We’ll just take her ourselves.”

The nine-year-old, curled into a

fetal position on the table, didn’t

care which vehicle would be

transporting her to the nearest

trauma center. She just wanted the

pain in her abdomen to go away, so

she could go back to school and

keep learning cursive. She couldn’t

understand why her parents were

panicking; after all, they were

doctors. They’d seen plenty of

pediatric patients with stomach

pain before. However, the image

that hung on the x-ray viewer

behind her would have unsettled

most seasoned physicians: an

unidentifiable mass overtook her

abdominal cavity and compressed

the vital organs within. Every

second counted. In the frightened

parents’ minds, there wasn’t time to

wait for a pediatric helicopter to fly

over 200 miles when they could

drive their daughter themselves.

Their Chevy Suburban broke a few

speed limits that day, but what’s a

speeding ticket compared to the life

of your child? That little girl was

me, and the choice my parents faced

that day is only one example of the

many ways that the rural healthcare

crisis continues to affect people

across the country.

Sixty million Americans live in an

area classified as “rural”; this

comprises a little less than 20% of

the American population. Only nine

percent of American physicians

practice in rural communities

(Rosenblatt, 2000). In the last 10

years, many of these rural Americans

have faced the closure of local

hospitals, 119 in total (Kahn,

Morgan, 2019); at that rate, 25% of

all rural hospitals will close within

the decade (NRHA, 2020). These

closures are primarily due to

financial circumstances unique to

rural areas: diminishing populations

are too small to support the existence

of high-profit specialty

departments and are less likely to

have high-paying insurances, while

Medicare’s Disproportionate Share

Hospital (DSH) policy disadvantages

rural hospitals compared to

urban ones. For Beverly Rollings of

Sedalia, Missouri (population of

22,000), the rural location of her

co-owned architecture firm directly

impacts the kind of insurance

options she’s able to offer her

employees: “In Pettis county…, if

you purchase through the Affordable

Care Act, you have one option.”

The limited network of this insurance

option doesn’t include providers

in Kansas City, the nearest

metropolitan area. One such

employee and his wife, after

learning that their unborn child had

polycystic kidney disease, were

forced to consider moving their

entire family to either Kansas City

or St. Louis in order to have some

kind of insurance coverage for the

treatment. After the insurance

company assured them that an

exception could be made in their

case, the couple chose to have a

C-section in Kansas City. Their

child, Simon, only lived for 12 hours

after birth. Following his death,

they received a bill for $50,000 in

the mail, as their insurance had

refused to cover the costs of their

procedure after all. The harsh

realities of this situation may be

shocking to some, but to inhabitants

of rural areas, it’s only another

anecdote highlighting the deficits

within the rural healthcare system.

Of the hospitals that remain open,

47% spend more money on a

monthly basis than is brought in,

leaving the future existence of these

hospitals in jeopardy (Kahn and

Morgan 2019). Hospital closures

cripple local economies, lead to

disinvestment in the area and

negatively impact a community’s

ability to attract other healthcare

providers to the area. For citizens

that already face a significant

commute to reach a healthcare facility,

these closures further limit the

ability of rural Americans to access

both emergency and preventative

care. In emergent cases, waiting an

additional 20 minutes for EMS to

arrive might mean the difference

between life and death. For farmers,

ranchers and other rural workers,

driving to a healthcare provider

may mean taking off work, which

delays the treatment of conditions

that otherwise might have been

preventable. Driving long distances

both delays the treatment of these

conditions and disincentivizes

people from consulting specialists.

Hospital closings have only increased

the distance people must

travel to gain access to basic

medical care. Dr. Roy Elfrink, a

general surgeon who’s worked in

Marshall, Missouri (population of

13,000) for over 25 years, notes that

low socioeconomic status and rural

culture both play a role in these

disparities.

28 29

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!